Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2026-02-03 @ 7:46 AM
Study NCT ID:
NCT01557959
Status:
COMPLETED
Last Update Posted:
2018-06-29
First Post:
2012-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Wake Forest University Health Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CCCWFU 62107
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None